Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 24 ... fluid and individual characteristics like age, sex, body mass index, smoking history and hormone therapy (in woman). A reliable threshold between normal and pathological pleural fluid ... Country:Slovenia, City:Ljubljana, Country:Slovenia, Life Sciences, Hormones, Treatment, Therapy, Physiology, Anthropology, University Medical Center. This article ...
2009 NOV 24 ... A new study, 'Parathyroid hormone administration may modulate periodontal tissue levels of interleukin-6, matrix ... and of MMP-2 in the T15 and T30 groups (p <0.05). Zymography assays demonstrated that treatment with parathyroid hormone led to a decrease in MMP-9 activity (p <0.01). TRAP staining ...
2009 NOV 25 ... of Surgery (Randomized Controlled Trial to Determine the Efficacy of Long-Term Growth Hormone Treatment in Severely Burned Children. Annals of Surgery, 2009;250(4):514-523). For ...
2009 NOV 25 ... for optimal surgical management, the use of radioiodine remnant ablation, thyroid hormone suppression therapy, as well as long-term surveillance based on ultrasound, other ... Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer. The new guidelines are published in ...
Subject: Mary Ann Liebert, Inc./Genetic Engineering News
2009 NOV 25 ... dihydrotestosterone. It is therefore of interest as a potential new therapeutic agent in hormone-dependent conditions and is under development as a nutraceutical," scientists writing ... States, Life Sciences, Pediatrics, Pharmacokinetics, Drugs, Pharmaceuticals, Therapy, Treatment, Endocrinology, Estrogen, Hormones, Women's Health, Biotechnology, Drug Development, ...
2009 NOV 23 ... men with hypopituitarism (age 53 center dot 1 +/- 4 center dot 1 years) with both growth hormone (GH) and testosterone deficiency were studied sequentially after 2 weeks of treatment ...
2009 NOV 23 ... mass probably determined by deregulation of locally produced factors. Anti-Mullerian hormone (AMH) is a glycoprotein that inhibits follicular recruitment and determines the size of ... Hyperandrogenism, Pharmaceuticals, Polycystic Ovary Syndrome, Testosterone, Therapy, Treatment, University of Chile. This article was prepared by Biotech Business Week ...
2009 NOV 23 ... implicated the renin angiotensin system in the cardiac hypertrophy induced by thyroid hormone. However, whether Angiotensin type 1 receptor (AT(1)R) is critically required to the ... of this receptor in primary cultures of neonatal cardiomyocytes submitted to T-3 (10 nM) treatment. The cardiomyocytes transfected with the AT(1)R siRNA presented reduced mRNA (90%, P< ...
2009 NOV 23 ... the United States, "Preclinical and clinical research findings have revealed that the hormone progesterone, when acutely administered, can dramatically reduce cerebral edema, ... Edema, Hormones, Inflammation, Medicinal Chemistry, Necrosis, Progesterone, Therapy, Treatment, Emory University. This article was prepared by Biotech Business Week ...
2009 NOV 23 ... observation and had more estrous days during the cycles. Levels of serum luteinizing hormone (LH) and follicle-stimulating hormone were measured for 5-6 consecutive days and were ... Drugs, Gonadotropin, Gynecology, Hormones, Menstruation, Pharmaceuticals, Therapy, Treatment, Women's Health, Kyushu University. This article was prepared by Biotech ...
2009 NOV 23 ... cancer survivors in the US. Most breast cancers in women 50 years of age and older are hormone receptor positive," scientists in the United States report. "Third ... All have been shown to be superior to tamoxifen in disease free survival (DFS) in the treatment of both metastatic and early breast cancers. While the data on side effects is limited, ...
2009 NOV 23 ... (Cyp19a1), and cyclin D2 (Ccnd2) mRNA compared with WT mice. Follicle-stimulating hormone treatment of granulosa cells from WT ovaries upregulated Fshr, Cyp19a1, and Ccnd2 expression. ...
2009 NOV 23 ... Takano and colleagues, Nihon University. The researchers concluded: "This hormone may be useful to prevent orthodontic relapse following orthodontic treatment." ...
2009 NOV 23 ... and lower numbers of corpora lutea. Sexual receptivity, examined after ovariectomy and hormone replacement, was normal in all groups except those neonatally exposed to EB. FOS ... Hormones, Lordosis, Neuroendocrinology, Pharmaceuticals, Physiology, Therapy, Treatment, Women's Health, North Carolina State University. This article was ...
2009 NOV 23 ... probe sets in each tissue with altered levels in hormone-treated versus control animals. Hormone treatment efficacy was confirmed by determination of serum hormone levels before and after ...
2009 NOV 25 ... (PTx). Successful surgical treatment often results in dramatic drop of the parathyroid hormone (PTH) levels, relieves the patients from clinical symptoms, and reduces mortality. ...
2009 NOV 23 ... of breast cancer adjuvant hormonal treatments,' is the subject of a report. "Adjuvant hormone therapy (HT) based on tamoxifen (TX) or aromatase inhibitors (AIs) has become the ... trial results, AI use is recommended by the American Society of Clinical Oncology for treatment of postmenopausal women with HR+ breast cancer," scientists writing in the Journal of ...
2009 NOV 23 ... A new study carried out at the University of Haifa has found that the hormone oxytocin, the "love hormone", which affects behaviors such as trust, empathy and ... Drugs, Hormones, Oxytocin, Pharmaceuticals, Psychiatry, Social Behavior, Therapy, Treatment, University of Haifa. This article was prepared by Biotech Business Week ...
2009 NOV 29 ... in their life than men: the risk increases after menopause, partly because of ovarian hormone deficiency that favours hypertension, diabetes, hyperlipidemia, central obesity and the ... Tuberculosis, Obesity, Oncology, Pathology, Rehabilitation Research, Stroke, Therapy, Treatment, Virology, Women's Health, European Society of Cardiology.This article was ...
